event of a recurrence and that earlier detection of this recurrence will lead to improved outcomes; a belief that is admittedly lacking in evidentiary support. 5 Years and Beyond Although the AUA and NCCN discuss imaging up to 5 years for
Search Results
Optimal Surveillance Strategies After Surgery for Renal Cell Carcinoma
Mark D. Tyson and Sam S. Chang
Cervical Cancer Screening
Edward E. Partridge, Nadeem Abu-Rustum, Anna Giuliano, Stewart Massad, Joan McClure, Mary Dwyer, and Miranda Hughes
transmitted disease, and chronic immunosuppression. Squamous cell carcinomas account for approximately 80% of all cervical cancers, and adenocarcinomas for approximately 20%. 10 Cervical cytology screening is the predominant method for early detection of
Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer
Ahmed A. Hussein, Umar Iqbal, Zhe Jing, Yousuf Ramahi, Holly Houenstein, Stephanie Newman, Blake Peterson, Katarina Krajacic, Adeena Samoni, Bo Xu, Norbert Sule, Gissou Azabdaftari, Eric C. Kauffman, James L. Mohler, Michael Kuettel, and Khurshid A. Guru
world. The NCCN Guidelines for Prostate Cancer 4 and for Prostate Cancer Early Detection 5 provide recommendations for early detection, evaluation, and treatment that seek to avoid overdiagnosis and overtreatment. Compliance with treatment guidelines
Advancing More Equitable Care Through the Development of a Health Equity Report Card
Alyssa A. Schatz, Shonta Chambers, Gretchen C. Wartman, Lisa A. Lacasse, Crystal S. Denlinger, Kristen M. Hobbs, Lindsey Bandini, Robert W. Carlson, and Robert A. Winn
of guideline-concordant care. Following these presentations, the working group members were assigned to small discussion groups across 4 key focus areas: (1) research and clinical trials, (2) risk reduction, prevention, and early detection, (3) care
Prostate Cancer, Version 2.2014
James L. Mohler, Philip W. Kantoff, Andrew J. Armstrong, Robert R. Bahnson, Michael Cohen, Anthony Victor D’Amico, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric Mark Horwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Timothy M. Kuzel, Richard J. Lee, Arnold W. Malcolm, David Miller, Elizabeth R. Plimack, Julio M. Pow-Sang, David Raben, Sylvia Richey, Mack Roach III, Eric Rohren, Stan Rosenfeld, Edward Schaeffer, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Cy Stein, Seth A. Strope, Jonathan Tward, Dorothy A. Shead, and Maria Ho
for 29,480 deaths in 2014. 1 This comparatively low death rate suggests that, unless prostate cancer is becoming biologically less aggressive, increased public awareness with earlier detection and treatment has begun to affect mortality from this
Non-Hodgkin’s Lymphomas, Version 3.2012
Andrew D. Zelenetz, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C. Byrd, Myron S. Czuczman, Luis Fayad, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nishitha Reddy, Lubomir Sokol, Lode Swinnen, Christina Tsien, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Maoko Naganuma, and Mary A. Dwyer
detected clinically at the same time as PET. Whether this earlier detection of relapse in a proportion of patients translates to improved outcomes is unclear. Diffuse Large B-Cell Lymphoma Considerable debate remains in the routine use of follow
Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer
Benjamin R. Roman, Snehal G. Patel, Marilene B. Wang, Anna M. Pou, F. Christopher Holsinger, David Myssiorek, David Goldenberg, Samuel Swisher-McClure, Alexander Lin, Jatin P. Shah, and Judy A. Shea
recurrence or second primary lesions in the treated head and neck cancer patient . Laryngoscope 2013 ; 123 : 2161 – 2164 . 32. Kostakoglu L Fardanesh R Posner M . Early detection of recurrent disease by FDG-PET/CT leads to management changes in
Treatment Patterns and Survival Outcomes in Patients With Breast Cancer on Medicaid, Pre- and Post-Expansion
Siran M. Koroukian, Weichuan Dong, Jeffrey M. Albert, Uriel Kim, Kirsten Eom, Johnie Rose, Cynthia Owusu, Kristine M. Zanotti, Gregory Cooper, and Jennifer Tsui
of diagnosis. We excluded women who joined Medicaid through the Ohio Breast and Cervical Cancer Early Detection Program or with missing data on treatment modalities (n=2,833; see Figure S1 in the supplementary materials , available online with this
Cancer Survivorship: We’ve Only Just Begun
Mary S. McCabe
Over the past decade, tremendous progress has been made in the early detection and effective treatment of many cancers, resulting in a growing population of cancer survivors in the United States that exceeds 13.7 million as of 2012. 1 With the 5
Ambulatory Oncology Operations: Strategies to Alleviate Complexity
Chadi Nabhan and Sandeep Parsad
of increased demand. 3 Factors Affecting Outpatient Delivery of Cancer Care In addition to a growing population of patients with cancer as a result of advances in earlier detection and the success of prolonged survival, the economy, new
